Omeros Corporation
97Patents
88Active
97Granted
54Portfolio score
Filing activity: Sep 11, 2000 → Aug 15, 2023 · 16 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6740100B2 | Tendon repair using adhesive | Human Necessities | 118 | Expired |
| US6492332B1 | Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation | Human Necessities | 79 | Expired |
| US7973068B2 | Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation | Human Necessities | 67 | Expired |
| US7067144B2 | Compositions and methods for systemic inhibition of cartilage degradation | Human Necessities | 64 | Expired |
| US7919094B2 | Methods for treating conditions associated with MASP-2 dependent complement activation | Chemistry; Metallurgy | 56 | Active |
| US6420432B2 | Surgical irrigation solution and method for inhibition of pain and inflammation | Emerging Cross-Sectional Technologies | 40 | Expired |
| US6645168B2 | Arthroscopic irrigation solution and method for inhibition of pain and inflammation | Emerging Cross-Sectional Technologies | 39 | Expired |
| US8652477B2 | Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation | Chemistry; Metallurgy | 36 | Active |
| US8840893B2 | Methods for treating conditions associated with MASP-2 dependent complement activation | Chemistry; Metallurgy | 22 | Active |
| US8173707B2 | Ophthalmologic irrigation solutions and method | Human Necessities | 18 | Active |
| US7091181B2 | Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors | Human Necessities | 16 | Expired |
| US8586633B2 | Ophthalmologic irrigation solutions and method | Human Necessities | 15 | Active |
| US9102724B2 | Anti-FZD10 monoclonal antibodies and methods for their use | Chemistry; Metallurgy | 15 | Active |
| US9066856B2 | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | Human Necessities | 14 | Active |
| US7786139B2 | PDE10 inhibitors and related compositions and methods | Chemistry; Metallurgy | 13 | Active |
| US9278101B2 | Ophthalmologic irrigation solutions and method | Human Necessities | 13 | Active |
| US8377930B2 | PDE10 inhibitors and related compositions and methods | Chemistry; Metallurgy | 11 | Active |
| US8343970B2 | PDE10 inhibitors and related compositions and methods | Emerging Cross-Sectional Technologies | 10 | Active |
| US9399040B2 | Ophthalmologic irrigation solutions and method | Human Necessities | 10 | Active |
| US7297348B2 | Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from | Human Necessities | 10 | Expired |
| US8278327B2 | PDE10 inhibitors and related compositions and methods | Chemistry; Metallurgy | 10 | Active |
| US8951522B2 | Methods for treating conditions associated with MASP-2 dependent complement activation | Chemistry; Metallurgy | 9 | Active |
| US9486406B2 | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | Human Necessities | 9 | Active |
| US9011860B2 | Compositions for inhibiting MASP-2 dependent complement activation | Chemistry; Metallurgy | 8 | Active |
| US9644035B2 | Methods for treating conditions associated with MASP-2 dependent complement activation | Chemistry; Metallurgy | 8 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.